CD38 and acute myeloid leukemia: Although several studies have described CD123 expression in large cohorts that included NPM1mut patients, no study had been designed to specifically analyze this AML subgroup or to compare CD123 fluorescence intensities between bulk AML cells and the CD34+CD38− population [13,15,19].